Skip to content
Clinical Trials – home
Rare disease

Neurofibromatosis

  • 7 clinical trials
Quick filters

7 Clinical trials

Countries:GermanyGermany
  • Participants:0–17 years
  • Sponsor:Merck Healthcare KGaA
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Crizotinib
  • Sponsor:Medical University Of Warsaw
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab Zirconium Zr-89
  • Sponsor:Leids Universitair Medisch Centrum (LUMC)
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
  • Substances:Trametinib
  • Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Selumetinib
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Selumetinib
  • Sponsor:AstraZeneca AB
See all trials →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.